Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

MDSAP Audits Go Remote During the Pandemic

  • Post author:Sam
  • Post published:December 11, 2020
  • Post category:The GMP Letter

Medical Device Single Audit Program (MDSAP) activities have continued during the COVID-19 pandemic, forcing auditors and device manufacturers to adapt to a virtual environment. Source: The GMP Letter

Continue ReadingMDSAP Audits Go Remote During the Pandemic

IMDRF Advances Device Conformity Assessment Documents

  • Post author:Sam
  • Post published:November 6, 2020
  • Post category:The GMP Letter

The International Medical Device Regulators Forum (IMDRF) made some progress toward global harmonization of device standards at its most recent meeting — held for the first time as a virtual…

Continue ReadingIMDRF Advances Device Conformity Assessment Documents

FDA Warns of Infection Risk From Heater-Coolers

  • Post author:Sam
  • Post published:November 6, 2020
  • Post category:The GMP Letter

The FDA has raised concerns about the risk of infections associated with CardioQuip’s modular heater-cooler device. Source: The GMP Letter

Continue ReadingFDA Warns of Infection Risk From Heater-Coolers

Health Canada Updates Guidelines on COVID-19 Testing

  • Post author:Sam
  • Post published:November 6, 2020
  • Post category:The GMP Letter

Health Canada is fast-tracking the review of submissions related to rapid antigen detection tests (RADTs) and nucleic acid tests and has released new guidance on antigen testing. Source: The GMP…

Continue ReadingHealth Canada Updates Guidelines on COVID-19 Testing

UK Establishes New Medical Device Information System

  • Post author:Sam
  • Post published:November 6, 2020
  • Post category:The GMP Letter

The United Kingdom will launch a new Medical Device Information System (MDIS) in January that aims to improve device monitoring and performance and link them to patient outcomes. Source: The…

Continue ReadingUK Establishes New Medical Device Information System

TGA Issues Guidance on Device Conformity Assessments During COVID-19

  • Post author:Sam
  • Post published:November 6, 2020
  • Post category:The GMP Letter

Australia’s Therapeutic Goods Administration (TGA) said that, in light of delays due to the COVID-19 pandemic and limitations on the number of notified bodies designated under the European Medical Devices…

Continue ReadingTGA Issues Guidance on Device Conformity Assessments During COVID-19

FDA Issues First Warning Letter for Product With a COVID-19-Related EUA

  • Post author:Sam
  • Post published:November 6, 2020
  • Post category:The GMP Letter

FDA hit Columbus, Ohio-based Battelle Memorial Institute with a warning letter for failure to comply with terms of its Emergency Use Authorization (EUA) for its decontamination system used for N95…

Continue ReadingFDA Issues First Warning Letter for Product With a COVID-19-Related EUA

Australia Invites Comment on Its Planned UDI System

  • Post author:Sam
  • Post published:October 8, 2020
  • Post category:The GMP Letter

Australia’s Therapeutics Goods Agency (TGA) has issued a new paper on its plan to establish a unique device identification (UDI) system and it wants to hear reactions from device sponsors.…

Continue ReadingAustralia Invites Comment on Its Planned UDI System

FDA Harmonizes eMDR System With International Codes

  • Post author:Sam
  • Post published:October 8, 2020
  • Post category:The GMP Letter

The FDA has updated its electronic medical device reporting (eMDR) system to include new fields for summary reports and combination products to harmonize with international reporting codes. Source: The GMP…

Continue ReadingFDA Harmonizes eMDR System With International Codes

Devicemakers Urged to Use ISO-10993-1 to Assess Biocompatibility

  • Post author:Sam
  • Post published:October 8, 2020
  • Post category:The GMP Letter

The FDA issued final guidance for devicemakers on the use of the ISO-10993-1 international standard for assessing the biocompatibility risks of devices that come into direct or indirect contact with…

Continue ReadingDevicemakers Urged to Use ISO-10993-1 to Assess Biocompatibility
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 44
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.